U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis.

Proceedings of the National Academy of Sciences of the United States of America
Arnaldo CarusoDario Di Luca

Abstract

Human herpesvirus 6 (HHV-6) is a lymphotropic virus, but recent observations showed that also vascular endothelial cells (ECs) are susceptible to infection, both in vivo and in vitro. The observation that lymph nodes are a site of viral persistence suggests that lymphatic ECs (LECs) might be even more relevant for HHV-6 biology than vascular ECs. Here, we provide evidence that HHV-6 can infect LECs in vitro and establish a latent infection. Thus HHV-6 infection induces the loss of angiogenic properties both in LECs and in vascular ECs, as shown by the inability to form capillary-like structures and to seal wound scratches. The antiangiogenic effects observed in infected cells are associated to the expression of HHV-6 U94/rep, a latency-associated gene. In fact, transfection of U94/rep or addition of recombinant U94/REP protein to ECs inhibits the formation of in vitro capillary-like structures, reduces migration of ECs, and blocks angiogenesis, rendering rat aortic rings insensitive to VEGF-induced vasculogenetic activity. The ability of U94/rep to block different angiogenetic steps may lead to approaches in the potential control of the proliferation of blood and lymphatic vessels.

References

Jun 1, 1991·The Journal of General Virology·K KondoK Yamanishi
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·G C KatsafanasN Frenkel
May 29, 1998·The Journal of General Virology·C A Wu, J D Shanley
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·A RotolaD Di Luca
Mar 31, 2000·Nature Medicine·P Carmeliet
Sep 23, 2000·Journal of Clinical Microbiology·A RotolaC Muneretto
Mar 22, 2002·Journal of Virology·Kazuhiro KondoKoichi Yamanishi
Mar 22, 2002·The Journal of General Virology·Panadda DhepaksonKoichi Yamanishi
Jun 29, 2002·Journal of Clinical Microbiology·S CollotS Ranger-Rogez
Apr 16, 2003·Journal of Medical Virology·Tetsushi YoshikawaYukihiro Nishiyama
May 27, 2003·Journal of Medical Virology·Arnaldo CarusoSimona Fiorentini
Oct 7, 2003·Oncogene·Tiziana ToniniPier Paolo Claudio
Sep 24, 2004·Biopolymers·Simona FiorentiniArnaldo Caruso
Oct 21, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Irina MaricStefania Pittaluga
Jun 24, 2005·Cancer Cell International·Ekwere T IfonLeonard Jason Rosenthal
Nov 2, 2005·Journal of Cellular Physiology·Emirena GarrafaArnaldo Caruso
Dec 22, 2005·Virology·Elisabetta CaselliDario Di Luca
Feb 19, 2008·The British Journal of Surgery·A R JohnM C Eggo
Jun 4, 2008·Annals of the New York Academy of Sciences·Suvendu Das, Mihaela Skobe
Jan 7, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Wolfram C M Dempke, Volker Heinemann

❮ Previous
Next ❯

Citations

Nov 28, 2012·Journal of Neurovirology·Nadia Ben-FredjElisabetta Caselli
Aug 21, 2013·Bulletin of Mathematical Biology·Michael J Plank, Matthew J Simpson
May 4, 2011·Reviews in Medical Virology·Kristof VranckenSandra Liekens
Sep 28, 2010·Journal of Medical Virology·Dharam V AblashiAnthony L Komaroff
Mar 19, 2016·Immunology Letters·Vincenzo GagliostroSilvano Sozzani
Apr 5, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·V StrengerC Urban
Jun 19, 2015·Archives of Virology·Elisabetta CaselliRoberta Rizzo
Jan 17, 2009·Cell Division·Adam J Hume, Robert F Kalejta
Mar 23, 2010·Orvosi hetilap·József OngrádiG Péter Medveczky
Aug 17, 2014·Current Opinion in Virology·Eric Zinn, Luk H Vandenberghe
Apr 3, 2012·The American Journal of Pathology·Hong MuJeffrey E Gershenwald
Dec 2, 2014·Current Opinion in Virology·Laurie T Krug, Philip E Pellett
Dec 2, 2017·Viruses·Eva EliassenIsabel Barao
Apr 19, 2018·American Journal of Reproductive Immunology : AJRI·Carolyn B CoulamSvetlana V Dambaeva
Mar 13, 2015·Clinical Microbiology Reviews·Henri AgutAgnès Gautheret-Dejean
Dec 28, 2019·Microorganisms·Elisabetta CaselliClodoveo Ferri
Mar 1, 2018·Pediatric Emergency Care·Thomas CristoforoLeslie F Carroll
Dec 14, 2018·Frontiers in Oncology·Eva EliassenStanley David Hudnall
Dec 14, 2019·Alzheimer's Research & Therapy·Daria BortolottiRoberta Rizzo
Apr 13, 2021·Frontiers in Immunology·Anthony L KomaroffJeffrey L Ecker
Apr 28, 2021·Mucosal Immunology·Evgeniya V Shmeleva, Francesco Colucci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.